Skip to content
Screener

Beam Therapeutics BEAM Other Non-Current Assets

Other Non-Current Assets at other companies

Arrowhead Research logo
Arrowhead ResearchARWR
$4.89M+272%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
$63M+4.8%
MGN
MagniteMGNI
$85.74M+1,289%
Wave Life Sciences logo
Wave Life SciencesWVE
$667K-8.4%
Intellia Therapeutics logo
Intellia TherapeuticsNTLA
$37.73M-53.0%
CRISPR Therapeutics logo
CRISPR TherapeuticsCRSP
$28.98M+39.5%

Other financials

Income statement

See full
Revenue$31.7M+325%
Operating income-$107.2M+10.1%
Net income-$94.3M+12.9%
EPS (diluted)-$0.91+26.0%

Balance sheet

See full
Cash & equivalents$288.3M-45.4%
Total debt$250.8M+58.6%
Total equity$1.2B+3.1%
Total assets$1.5B+0.9%

Cash flow

See full
Operating cash flow-$128.5M-23.7%
CapEx$2.2M-27.2%
Free cash flow-$130.7M-22.2%

Valuation

See full
Market cap$2.84B+63.5%
Enterprise value$2.8B+74.1%
P/S17.3×-11.5×

Profitability

See full
Operating margin-226.6%-90.5pp
Net margin-742.7%
FCF margin-234%-86.6pp

Returns & leverage

See full
Return on equity-47.1%
Debt / equity0.2×+0.1×
Current ratio17×+8.2×

Where this comes from

Reported directly by Beam Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The source filing: Beam Therapeutics’s 10-Q, filed May 7, 2026.

Filed
May 7, 2026, 7:22 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-210338
Line itemMarch 31,2026December 31,2025
Property and equipment, net101,247104,500
Restricted cash6,6936,676
Operating lease right-of-use assets98,148100,679
Other assets7,757634
Total assets$1,480,798$1,481,177
Liabilities and stockholders’ equity
Current liabilities:
Accounts payable$12,286$10,231

Item 1. Financial Statements (Unaudited)

FAQ

What is Beam Therapeutics's other non-current assets?
Beam Therapeutics (BEAM) reported other non-current assets of $7.76M in Q1 2026.
How has Beam Therapeutics's other non-current assets changed year-over-year?
Beam Therapeutics's other non-current assets increased by 751.5% year-over-year, from $911K to $7.76M.
What is the long-term trend for Beam Therapeutics's other non-current assets?
Over 5 years (2020 to 2025), Beam Therapeutics's other non-current assets has grown at a -27.4% compound annual growth rate (CAGR), from $3.14M to $634K.
What does other non-current assets mean?
Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.

Ask your AI about Beam Therapeutics's other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude